Acquired resistance or tolerance? - in search of mechanisms underlying changes in the resistance profile of Candida albicans and Candida parapsilosis as a result of exposure to methotrexate.

Antifungal resistance Antifungal tolerance Candida albicans Candida parapsilosis Methotrexate

Journal

Journal de mycologie medicale
ISSN: 1773-0449
Titre abrégé: J Mycol Med
Pays: France
ID NLM: 9425651

Informations de publication

Date de publication:
15 Mar 2024
Historique:
received: 11 01 2024
revised: 29 02 2024
accepted: 11 03 2024
medline: 21 3 2024
pubmed: 21 3 2024
entrez: 20 3 2024
Statut: aheadofprint

Résumé

The increasing prevalence of fungal strains showing acquired resistance and multidrug resistance is an increasing therapeutic problem, especially in patients with a severely weakened immune system and undergoing chemotherapy. What is also extremely disturbing is the similarity of the resistance mechanisms of fungal cells and other eukaryotic cells, including human cells, which may contribute to the development of cross-resistance in fungi in response to substances used in e.g. anticancer treatment. An example of such a drug is methotrexate, which is pumped out of eukaryotic cells by ABC transmembrane transporters - in fungi, used to remove azoles from fungal cells. For this reason, the aim of the study was to analyze the expression levels of genes: ERG11, MDR1 and CDR1, potentially responsible for the occurrence of cross-resistance in Candida albicans and Candida parapsilosis as a result of fungal exposure to methotrexate (MTX). In vitro exposure of C. albicans and C. parapsilosis strains to methotrexate showed a high increase in resistance to fluconazole and a partial increase in resistance to voriconazole. Analysis of the expression of resistance genes showed varied responses of the tested strains depending on the species. In the case of C. albicans, an increase in the expression of the MDR1 gene was observed, and a decrease in ERG11 and CDR1. However, for C. parapsilosis there was an increase in the expression of the CDR1 gene and a decrease in ERG11 and MDR1. We noted the relationship between the level of resistance to voriconazole and the level of ERG11 gene expression in C. albicans. This indicates that this type of relationship is different for each species. Our research confirms that the mechanisms by which fungi acquire resistance and develop cross-resistance are highly complex and most likely involve several pathways simultaneously. The emergence of multidrug resistance may be related to the possibility of developing tolerance to antimycotics by fungi.

Identifiants

pubmed: 38507825
pii: S1156-5233(24)00017-9
doi: 10.1016/j.mycmed.2024.101476
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

101476

Informations de copyright

Copyright © 2024 The Author(s). Published by Elsevier Masson SAS.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Katarzyna Góralska (K)

Department of Biology and Parasitology, Chair of Biology and Medical Microbiology, Medical University of Lodz. Żeligowskiego Street 7/9 90-752 Lodz, Poland. Electronic address: katarzyna.goralska@umed.lodz.pl.

Małgorzata Szybka (M)

Department of Microbiology and Medical Laboratory Immunology, Chair of Biology and Medical Microbiology, Medical University of Lodz. Pomorska Street 251 (Building C5) 92-213 Lodz, Poland.

Filip Franciszek Karuga (FF)

Department of Biology and Parasitology, Chair of Biology and Medical Microbiology, Medical University of Lodz. Żeligowskiego Street 7/9 90-752 Lodz, Poland; Department of Sleep Medicine and Metabolic Disorders, Medical University of Lodz, 90-419 Lodz, Poland.

Dorota Pastuszak-Lewandoska (D)

Department of Microbiology and Medical Laboratory Immunology, Chair of Biology and Medical Microbiology, Medical University of Lodz. Pomorska Street 251 (Building C5) 92-213 Lodz, Poland.

Ewa Brzeziańska-Lasota (E)

Department of Biomedicine and Genetics, Chair of Biology and Medical Microbiology, Medical University of Lodz. Mazowiecka Street 5 (Building A6) 92-215 Lodz, Poland.

Classifications MeSH